Company intelligence / Profile preview

BioMEMS Analytics

Bloomfield Hills, Michigan, United States

Ownership: Private
Development stage: Other

Overview

Limited clinical testing conducted for inflammation, fertility, autoimmune, and anti-aging biomarkers using spiked samples. Clinical validation planned to begin in late summer/early fall 2022 via academic researchers.

Therapeutic areas: ImmunologyOtherWomen's HealthInfectious DiseasesMetabolic Disorders
Modalities: Device
Industry: Protein Biomarker Diagnostics

Partnerships

Multinational based in Geneva (saliva-based Vit B panel)Prospective corporate customers for aging and iron deficiency panels

Beyond the preview

Go deeper on BioMEMS Analytics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioMEMS Analytics.

Explore the full profile